Latest / Philadelphia News Today | 2 Min News | The Daily News Now!
FDA Approves First Alzheimer’s Drug in Years | Philadelphia News
FDA just approved Leqembi, the first drug in years to slow Alzheimer’s progression by clearing brain amyloid plaques—slowing decline by 17% in trials. While hailed as a breakthrough by patient advocates, doctors warn of rare but serious side effects like brain swelling. Eisai plans U.S. rollout with strict monitoring. Not a cure, but a major step forward for millions. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:advertise@thednn.ai This is an automated, high-level news summary based on public reporting.Report issues to feedback@thednn.ai. View…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.